Unique Ingredient Identifier M28OL1HH48 is listed as a ingredient substance
| RN | 74811-65-7 |
| NCIT | C80923 |
| RXCUI | 1310573 |
| PUBCHEM | 6328154 |
| MF | Polymer substance not supported |
UNII M28OL1HH48 CROSCARMELLOSE SODIUM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | INJECTION | 1 %W/V |
| ORAL | CAPSULE | 65.6 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 30 MG |
| ORAL | CAPSULE, COATED PELLETS | 24.75 MG |
| ORAL | CAPSULE, DELAYED ACTION | 24 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 20 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 7.3 MG |
| ORAL | CAPSULE, GELATIN COATED | 9 MG |
| ORAL | CAPSULE, HARD GELATIN | 30 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 65.6 MG |
| ORAL | DISPERSIBLE TABLET | 8 MG |
| ORAL | GRANULE | 16.1 MG |
| ORAL | GRANULE, FOR RECONSTITUTION | 143.5 MG |
| ORAL | GRANULE, FOR SUSPENSION | 35.3 MG |
| ORAL | POWDER, FOR SUSPENSION | 11.25 MG |
| ORAL | SOLUTION | NA |
| ORAL | SUSPENSION | 50 MG/5ML |
| ORAL | TABLET | 180 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 32 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 100 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 25.5 MG |
| ORAL | TABLET, CHEWABLE | 18 mg |
| ORAL | TABLET, COATED | 35.2 MG |
| ORAL | TABLET, DELAYED ACTION | 51.51 MG |
| ORAL | TABLET, DELAYED ACTION, COATED | 32 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 32.44 MG |
| ORAL | TABLET, DELAYED RELEASE | 45 MG |
| ORAL | TABLET, EXTENDED RELEASE | 90 MG |
| ORAL | TABLET, FILM COATED | 165 MG |
| ORAL | TABLET, FOR SUSPENSION | 11.6 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 48 MG |
| ORAL | TABLET, SUGAR COATED | 2.5 MG |
| ORAL | TABLET, SUSTAINED ACTION | 28 MG |
| ORAL | TABLET, UNCOATED, TROCHE | 10 MG |
| ORAL-20 | TABLET | 80 mg |
| SUBLINGUAL | TABLET | 10 MG |